Community Based Trial for AMEVIVE®

PHASE4CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Moderate to Severe Chronic Plaque Psoriasis
Interventions
DRUG

Alefacept

IM

Trial Locations (36)

11787

Marina I Peredo, Smithtown

12701

Catskill Dermatology, Monticello

14221

Buffalo Medical Group, Williamsville

19462

Dermatology Assoc of Plymouth Meeting, Plymouth Meeting

22601

Stephen Flax, Winchester

28401

Wilmington Health Associates Dermatology, Wilmington

30004

Atlanta Derm, Vein & Research Center, Alpharetta

33309

Skin and Cancer Associates, Tamarac

33602

Michael Scannon, Tampa

35203

Monheit Dermatology Associates, Birmingham

36532

Bayshore Dermatology, Fairhope

37201

Gold Skin Care, Nashville

37902

Dermatology Associates of Knoxville, Knoxville

40701

Melissa Knuckles, Corbin

44481

Robert Brodell, Warren

49503

Psoriasis Treatment Center, Grand Rapids

60004

Altman Dermatology Associates, Arlington Heights

60007

Michael Greenberg, Elk Grove Village

60477

Calumet Dermatology Associates, Calumet City

61354

David J. Coynik, Peru

75201

Texas Dermatology Research, Dallas

75601

Mark Wallis, Longview

77401

Bellaire Dermatology Associates, Bellaire

78201

Stephen Miller, San Antonio

80014

Front Dermatology, Denver

89101

Woodson Clinical Studies Group, Inc., Las Vegas

92501

Integrated Research Group, Riverside

93301

Bakersfield Dermatology & Skin Cancer Medical Group, Bakersfield

94582

Robert Greenberg, San Ramon

96701

Pearlridge Dermatology, ‘Aiea

97470

Dermatology & Laser Center of Roseberg, Roseburg

98225

Dermatology & Laser Center, Bellingham

99501

Jayne Fortson, Anchorage

02360

Richard Eisen, Plymouth

03060

Nashua Dermatology, Nashua

08512

Jerry Bagel, East Windsor

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Biogen

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY